In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 24th, 2004 | 13 | Yes |
Popular Name: 4-phenylpyrimidin-2-amine 4-phenylpyrimidin-2-amine
Find On: PubMed — Wikipedia — Google
CAS Numbers: 2305-87-5 , N/A , [2305-87-5]
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.49 | 5.55 | -7.24 | 2 | 3 | 0 | 52 | 171.203 | 1 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
MP | 162 - 164 | Enamine Building Blocks |
MP | 162...164 | Enamine Building Blocks |
MP | 164-166° | Oakwood Chemical |
MP | 165-166 | Fluorochem |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 95% | Fluorochem |
Purity | 95+% | Matrix Scientific |
Purity | 98% | Fluorochem |
Warnings | IRRITANT | Matrix Scientific |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HS90A-2-E | Heat Shock Protein HSP 90-alpha (cluster #2 Of 4), Eukaryotic | Eukaryotes | 290 | 0.70 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HS90A_HUMAN | P07900 | Heat Shock Protein HSP 90-alpha, Human | 290 | 0.70 | Binding ≤ 1μM |
HS90A_HUMAN | P07900 | Heat Shock Protein HSP 90-alpha, Human | 290 | 0.70 | Binding ≤ 10μM |
Description | Species |
---|---|
Attenuation phase | |
eNOS activation | |
EPHA-mediated growth cone collapse | |
HSF1 activation | |
HSF1-dependent transactivation | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
Recruitment of mitotic centrosome proteins and complexes | |
Regulation of actin dynamics for phagocytic cup formation | |
Regulation of PLK1 Activity at G2/M Transition | |
Scavenging by Class F Receptors | |
Sema3A PAK dependent Axon repulsion | |
Signaling by constitutively active EGFR | |
Signaling by ERBB2 | |
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated vascular permeability | |
vRNP Assembly |